CN Patent

CN1280574A — 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物

Assigned to Reddy And Chemino · Expires 2001-01-17 · 25y expired

What this patent protects

本发明涉及新的抗肥胖和促血胆固醇减少的化合物、其衍生物、类似物、互变异构形式、立体异构体、多晶型物、可药用盐、可药用溶剂化物、和含有它们的可药用组合物。更具体来说,本发明涉及通式(Ⅰ)新的β－芳基－α－氧取代的烷基羧酸、其衍生物、类似物、互变异构形式、立体异构体、多晶型物、可药用盐、可药用溶剂化物、和含有它们的可药用组合物。

USPTO Abstract

本发明涉及新的抗肥胖和促血胆固醇减少的化合物、其衍生物、类似物、互变异构形式、立体异构体、多晶型物、可药用盐、可药用溶剂化物、和含有它们的可药用组合物。更具体来说,本发明涉及通式(Ⅰ)新的β－芳基－α－氧取代的烷基羧酸、其衍生物、类似物、互变异构形式、立体异构体、多晶型物、可药用盐、可药用溶剂化物、和含有它们的可药用组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN1280574A
Jurisdiction
CN
Classification
—
Expires
2001-01-17
Drug substance claim
No
Drug product claim
No
Assignee
Reddy And Chemino
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.